Results of the rubella elimination program in Catalonia (Spain), 2002

Results of the rubella elimination program in Catalonia (Spain), 2002–2011

Published:2013-03-18 Issue:3 Volume:9 Page:642-648
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Barrabeig Irene,Torner Nuria,Martínez Ana,Carmona Gloria,Ciruela Pilar,Batalla Joan,Costa Josep,Hernández Sergi,Salleras Luis,Domínguez Angela,Group of Catalonia the Rubella Surveillance

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/hv.23260

Reference40 articles.

1. Hobman T, Chanter J. Rubella virus. In: Knipe DM, Howley PM. Fields Virology. 5th ed. Philadelphia: Wolters Kluwer 2007:1069-100.

2. Cooper LZ. The burden of congenital rubella syndrome. In: de Quadros CA, ed. Vaccines. Preventing Disease & Protecting Health. Washington: Pan American Health Organization, 2004:53-64.

3. Gershon AA. Rubella virus (German measles). In: Mandell Gl, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Churchill Livingstone,2010: 2127-32.

4. American Academy of Pediatrics. Rubella. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. Red Book: 2012 Report of the Committee on Infectious Diseases. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics, 2012: 629-34.

5. Research priorities for global measles and rubella control and eradication

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LIVE ATTENUATED VACCINES FOR THE IMMUNOPROPHYLAXIS;Russian Journal of Infection and Immunity;2017-01-01

2. The etiology of Rubella IgM positivity in patients with rubella-like illness in Iran from 2011 to 2013;Journal of Medical Virology;2015-05-19

3. Rubella susceptibility in pregnant women and results of a postpartum immunization strategy in Catalonia, Spain;Vaccine;2015-04

4. Are healthcare workers immune to rubella?;Human Vaccines & Immunotherapeutics;2013-12-19